MXPA05007612A - Uso de l-carnitina para el tratamiento de enfermedades cardiovasculares. - Google Patents
Uso de l-carnitina para el tratamiento de enfermedades cardiovasculares.Info
- Publication number
- MXPA05007612A MXPA05007612A MXPA05007612A MXPA05007612A MXPA05007612A MX PA05007612 A MXPA05007612 A MX PA05007612A MX PA05007612 A MXPA05007612 A MX PA05007612A MX PA05007612 A MXPA05007612 A MX PA05007612A MX PA05007612 A MXPA05007612 A MX PA05007612A
- Authority
- MX
- Mexico
- Prior art keywords
- carnitine
- treatment
- grams
- day
- cardiovascular diseases
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 229960001518 levocarnitine Drugs 0.000 title 1
- 206010000891 acute myocardial infarction Diseases 0.000 abstract 2
- 230000034994 death Effects 0.000 abstract 1
- 231100000517 death Toxicity 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000178A ITRM20030178A1 (it) | 2003-04-17 | 2003-04-17 | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
| PCT/IT2004/000107 WO2004091602A1 (en) | 2003-04-17 | 2004-03-03 | Use of l-carnitine for the treatment of cardiovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05007612A true MXPA05007612A (es) | 2005-09-30 |
Family
ID=29765768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05007612A MXPA05007612A (es) | 2003-04-17 | 2004-03-03 | Uso de l-carnitina para el tratamiento de enfermedades cardiovasculares. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20060052450A1 (https=) |
| EP (1) | EP1613301A1 (https=) |
| JP (1) | JP2006523685A (https=) |
| KR (1) | KR20050121196A (https=) |
| CN (2) | CN101467992A (https=) |
| AU (2) | AU2004229256A1 (https=) |
| BR (1) | BRPI0406552A (https=) |
| CA (1) | CA2508636A1 (https=) |
| IT (1) | ITRM20030178A1 (https=) |
| MX (1) | MXPA05007612A (https=) |
| WO (1) | WO2004091602A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20040346A1 (it) * | 2004-07-13 | 2004-10-13 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
| US20070260674A1 (en) * | 2006-05-02 | 2007-11-08 | Research In Motion Limited | Push framework for delivery of dynamic mobile content |
| JP2011515471A (ja) * | 2008-03-26 | 2011-05-19 | オーソロジック コーポレイション | 急性心筋梗塞を処置するための方法 |
| EP2353596A1 (en) | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| SI2704734T1 (sl) | 2011-05-03 | 2015-08-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Sestavek, uporaben za zdravljenje motenj lipidnega metabolizma |
| CN114073705B (zh) * | 2020-08-14 | 2026-03-10 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种降尿酸药物组合物及其应用 |
| CN112180013B (zh) * | 2020-09-29 | 2022-11-15 | 上海脉示生物技术有限公司 | 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS531812B2 (https=) * | 1972-12-07 | 1978-01-23 | ||
| EP1133289A1 (en) * | 1998-11-26 | 2001-09-19 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Use of fumarate salt of l-carnitine or its alkanoyl derivatives in ischaemia |
-
2003
- 2003-04-17 IT IT000178A patent/ITRM20030178A1/it unknown
-
2004
- 2004-03-03 JP JP2006507635A patent/JP2006523685A/ja active Pending
- 2004-03-03 CN CNA2008101490996A patent/CN101467992A/zh active Pending
- 2004-03-03 BR BR0406552-2A patent/BRPI0406552A/pt not_active IP Right Cessation
- 2004-03-03 CA CA002508636A patent/CA2508636A1/en not_active Abandoned
- 2004-03-03 KR KR1020057013711A patent/KR20050121196A/ko not_active Ceased
- 2004-03-03 US US10/538,868 patent/US20060052450A1/en not_active Abandoned
- 2004-03-03 AU AU2004229256A patent/AU2004229256A1/en not_active Withdrawn
- 2004-03-03 EP EP04716692A patent/EP1613301A1/en not_active Ceased
- 2004-03-03 WO PCT/IT2004/000107 patent/WO2004091602A1/en not_active Ceased
- 2004-03-03 MX MXPA05007612A patent/MXPA05007612A/es active IP Right Grant
- 2004-03-03 CN CNA2004800015143A patent/CN1717232A/zh active Pending
-
2010
- 2010-06-14 AU AU2010202396A patent/AU2010202396A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006523685A (ja) | 2006-10-19 |
| BRPI0406552A (pt) | 2005-12-20 |
| AU2010202396A1 (en) | 2010-07-01 |
| AU2004229256A1 (en) | 2004-10-28 |
| CN1717232A (zh) | 2006-01-04 |
| US20060052450A1 (en) | 2006-03-09 |
| EP1613301A1 (en) | 2006-01-11 |
| KR20050121196A (ko) | 2005-12-26 |
| ITRM20030178A0 (it) | 2003-04-17 |
| ITRM20030178A1 (it) | 2004-10-18 |
| WO2004091602A1 (en) | 2004-10-28 |
| CA2508636A1 (en) | 2004-10-28 |
| CN101467992A (zh) | 2009-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
| BRPI0509139A (pt) | composição, e, método de estimulação de uma resposta imune em um indivìduo, de tratamento profilático de uma doença, de melhoramento de um sinal ou sintoma associado com uma doença, de alvejamento de um tumor, de inibição do crescimento de tumor, e de detecção de um tumor | |
| EP1369119B1 (en) | Il-12 expression controlling agents | |
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| MXPA05012810A (es) | Formas de dosis oral de memantina. | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| NO20082672L (no) | Anvendelse av cikletanin og andre fluorpyridiner for behandling av systolisk-dominant hypertensjon, isolert hypertensjon, oket pulstrykk og generell hypertensjon | |
| MXPA05007612A (es) | Uso de l-carnitina para el tratamiento de enfermedades cardiovasculares. | |
| ZA200609266B (en) | Treatment of t-cell lymphoma using 10-propargyl-10-deaza-aminopterin | |
| RU2003127718A (ru) | Применение флумазенила в производстве лекарственного средства для лечения кокаиновой зависимости | |
| BR0009380A (pt) | Tratamento de câncer melhorado comtemozolomida | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| ES2312657T3 (es) | Utilizacion de desoxipeganina en el tratamiento de la depresion clinica. | |
| HUP0401798A2 (hu) | Rosuvastatin alkalmazása demencia előtti állapotokban használható gyógyszerkészítmény előállítására | |
| MX2021008986A (es) | Metodos de tratamiento de un paciente con enfermedad de parkinson. | |
| ATE422883T1 (de) | Verwendung von carnitinen zur prävention und/oder behandlung von krankheiten die durch die andropause verursacht werden | |
| RU2002116408A (ru) | Способ реперфузионной терапии больных острым инфарктом миокарда | |
| JP2015500836A5 (https=) | ||
| CA2469702A1 (en) | Darifenacin for use in the treatment of urgency induced by overactive bladder | |
| RU2002111257A (ru) | Способ лечения больных с ишемическим инсультом | |
| PL1773314T3 (pl) | Zastosowanie L-karnityny do leczenia chorób naczyniowo-sercowych | |
| TW200501967A (en) | Nemorubicin for use in the preparation of a medicament for liver disease | |
| RU2005102282A (ru) | Способ лечения тревожно-депрессивных расстройств и вегетативного дисбаланса у больных острым инфарктом миокарда | |
| RU2002122034A (ru) | Способ коррекции метаболических, иммунологических и дисбиотических нарушений в раннем послеоперационном периоде у больных, перенесших различные операции по поводу рака желудка | |
| Serracino Inglott et al. | Prevalence and drug treatment of the Parkinsonian syndrome in Malta |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |